Matches in SemOpenAlex for { <https://semopenalex.org/work/W2981642049> ?p ?o ?g. }
Showing items 1 to 81 of
81
with 100 items per page.
- W2981642049 abstract "Abstract Background The genus Burkholderia contains several pathogenic species with distinct etiologies, including Burkholderia pseudomallei the biothreat pathogen responsible for melioidosis and Burkholderia mallei which causes glanders. β-Lactams, such as ceftazidime and meropenem, are important therapeutic options for these infections. However, clinical resistance to β-lactams, which is primarily mediated by multiple types of β-lactamases in these species, is a growing concern. Durlobactam (ETX2514, DUR) is a novel β-lactamase inhibitor with broad-spectrum activity against Ambler class A, C, and D β-lactamases. Sulbactam (SUL) is an Ambler Class A β-lactamase inhibitor with intrinsic antibacterial activity against a limited number of species, including Acinetobacter spp. SUL-DUR is currently in Phase 3 clinical testing for the treatment of carbapenem-resistant infections caused by Acinetobacter spp. In this study, SUL-DUR was tested for in vitro antibacterial activity against B. pseudomallei and B. mallei as well as for in vivo efficacy in a preclinical model of melioidosis. Methods The antibacterial activity of SUL alone or in combination with DUR (fixed at 4 mg/L) against B. pseudomallei (n = 30) and B. mallei (N = 28) was determined following CLSI guidelines. In vivo efficacy was tested in an acute murine model of melioidosis in which 4 × 104 cfu Bp K96423 (SUL-DUR MIC = 1 mg/L) was administered intranasally to BalbC mice. SUL-DUR (100/200 or 400/200 mg/kg) was administered q4h subcutaneously 4 hours post-challenge for 6 days and murine survival was monitored for 45 days. Doxycycline (DOX) and ciprofloxacin (CIP) were dosed as positive controls at 40 mg/kg q12 h for 6 days. Results The addition of DUR effectively lowered the SUL MIC50/90 from 8/16 to 0.25/0.5 mg/L vs. B. pseudomallei and from 8/8 to 1/2 mg/L for B. mallei. All untreated mice in the melioidosis model succumbed to infection within 3 days of challenge. 60% survival was observed for both dose arms of SUL-DUR as compared with 40% survival observed for both CIP and DOX. Conclusion Preliminary preclinical data demonstrating robust in vitro and in vivo antibacterial activity of SUL-DUR against Burkholderia spp. suggests this combination may be an effective new therapy for the treatment of these challenging pathogens. Disclosures All authors: No reported disclosures." @default.
- W2981642049 created "2019-11-01" @default.
- W2981642049 creator A5006271408 @default.
- W2981642049 creator A5034761589 @default.
- W2981642049 creator A5050599439 @default.
- W2981642049 creator A5056061775 @default.
- W2981642049 creator A5066383678 @default.
- W2981642049 date "2019-10-01" @default.
- W2981642049 modified "2023-10-16" @default.
- W2981642049 title "709. In Vitro Antibacterial Activity and In Vivo Efficacy of Sulbactam–Durlobactam (ETX2514SUL) Against Pathogenic Burkholderia Species" @default.
- W2981642049 doi "https://doi.org/10.1093/ofid/ofz360.777" @default.
- W2981642049 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6811307" @default.
- W2981642049 hasPublicationYear "2019" @default.
- W2981642049 type Work @default.
- W2981642049 sameAs 2981642049 @default.
- W2981642049 citedByCount "0" @default.
- W2981642049 crossrefType "journal-article" @default.
- W2981642049 hasAuthorship W2981642049A5006271408 @default.
- W2981642049 hasAuthorship W2981642049A5034761589 @default.
- W2981642049 hasAuthorship W2981642049A5050599439 @default.
- W2981642049 hasAuthorship W2981642049A5056061775 @default.
- W2981642049 hasAuthorship W2981642049A5066383678 @default.
- W2981642049 hasBestOaLocation W29816420491 @default.
- W2981642049 hasConcept C150903083 @default.
- W2981642049 hasConcept C207001950 @default.
- W2981642049 hasConcept C2776968632 @default.
- W2981642049 hasConcept C2777637488 @default.
- W2981642049 hasConcept C2778478555 @default.
- W2981642049 hasConcept C2778512257 @default.
- W2981642049 hasConcept C2778523567 @default.
- W2981642049 hasConcept C2779110727 @default.
- W2981642049 hasConcept C2779375183 @default.
- W2981642049 hasConcept C2779631663 @default.
- W2981642049 hasConcept C2779775996 @default.
- W2981642049 hasConcept C2780416669 @default.
- W2981642049 hasConcept C2780855054 @default.
- W2981642049 hasConcept C501593827 @default.
- W2981642049 hasConcept C523546767 @default.
- W2981642049 hasConcept C54355233 @default.
- W2981642049 hasConcept C71924100 @default.
- W2981642049 hasConcept C86803240 @default.
- W2981642049 hasConcept C89423630 @default.
- W2981642049 hasConcept C94665300 @default.
- W2981642049 hasConceptScore W2981642049C150903083 @default.
- W2981642049 hasConceptScore W2981642049C207001950 @default.
- W2981642049 hasConceptScore W2981642049C2776968632 @default.
- W2981642049 hasConceptScore W2981642049C2777637488 @default.
- W2981642049 hasConceptScore W2981642049C2778478555 @default.
- W2981642049 hasConceptScore W2981642049C2778512257 @default.
- W2981642049 hasConceptScore W2981642049C2778523567 @default.
- W2981642049 hasConceptScore W2981642049C2779110727 @default.
- W2981642049 hasConceptScore W2981642049C2779375183 @default.
- W2981642049 hasConceptScore W2981642049C2779631663 @default.
- W2981642049 hasConceptScore W2981642049C2779775996 @default.
- W2981642049 hasConceptScore W2981642049C2780416669 @default.
- W2981642049 hasConceptScore W2981642049C2780855054 @default.
- W2981642049 hasConceptScore W2981642049C501593827 @default.
- W2981642049 hasConceptScore W2981642049C523546767 @default.
- W2981642049 hasConceptScore W2981642049C54355233 @default.
- W2981642049 hasConceptScore W2981642049C71924100 @default.
- W2981642049 hasConceptScore W2981642049C86803240 @default.
- W2981642049 hasConceptScore W2981642049C89423630 @default.
- W2981642049 hasConceptScore W2981642049C94665300 @default.
- W2981642049 hasLocation W29816420491 @default.
- W2981642049 hasLocation W29816420492 @default.
- W2981642049 hasOpenAccess W2981642049 @default.
- W2981642049 hasPrimaryLocation W29816420491 @default.
- W2981642049 hasRelatedWork W10018251 @default.
- W2981642049 hasRelatedWork W14878539 @default.
- W2981642049 hasRelatedWork W1548797 @default.
- W2981642049 hasRelatedWork W252288 @default.
- W2981642049 hasRelatedWork W5141108 @default.
- W2981642049 hasRelatedWork W7534746 @default.
- W2981642049 hasRelatedWork W1145932 @default.
- W2981642049 hasRelatedWork W12786530 @default.
- W2981642049 hasRelatedWork W14693358 @default.
- W2981642049 hasRelatedWork W16603112 @default.
- W2981642049 isParatext "false" @default.
- W2981642049 isRetracted "false" @default.
- W2981642049 magId "2981642049" @default.
- W2981642049 workType "article" @default.